The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Stages I-II non-small cell lung cancer treated using either lobectomy by video-assisted thoracoscopic surgery (VATS) or stereotactic ablative radiotherapy (SABR): Outcomes of a propensity score-matched analysis.
Suresh Senan
Consultant or Advisory Role - Varian Medical Systems
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems
Naomi E Verstegen
No relevant relationships to disclose
David Palma
No relevant relationships to disclose
George Rodrigues
No relevant relationships to disclose
Frank J Lagerwaard
Honoraria - BrainLAB; Varian Medical Systems
A van der Elst
No relevant relationships to disclose
R Mollema
No relevant relationships to disclose
W F van Tets
No relevant relationships to disclose
Andrew Warner
No relevant relationships to disclose
J J.A. Joosten
No relevant relationships to disclose
M I Amir
No relevant relationships to disclose
Cornelis J Haasbeek
No relevant relationships to disclose
Egbert F Smit
No relevant relationships to disclose
Ben J. Slotman
Honoraria - BrainLAB; Varian Medical Systems
Research Funding - Varian Medical Systems
J W Oosterhuis
No relevant relationships to disclose